Start of the Crowdinvesting campaign
On Sunday November 26th, the ImmunoLogik team around the CEO Dr. Christian Setz and the scientific advisor Prof. Dr. Ulrich Schubert started their crowdinvesting campaign on aescuvest. Only there you have the chance to invest and participate in the innovative development of the lead candidate IML-106 for the efficient and essential treatment of patients who have exploited all available means of the modern therapy, and who would die due to the unavoidable outbreak of AIDS.
Learn more & save the early-investor bonus on www.aescuvest.de/immunologik
Warning: This investment carries considerable risks and may lead to a complete loss of the assets invested.
Comments are closed.